Validation of a remote monitoring blood pressure device in a general population cohort
American Journal of Hypertension · 01.09.2026 · 39 (9) · 1076-1082
DOI: 10.1093/ajh/hpag042 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift American Journal of Hypertension, online erschienen am 19.06.2026. Verfasst von Matthew D Moore und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, United States. Hauptthemen laut MEDLINE: Blood Pressure, Hypertension, Blood Pressure Determination, Blood Pressure Monitors. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH, NHLBI NIH HHS, Center for Women's Reproductive Health Pilot.
Abstract (Originalsprache)
Background
Remote blood pressure (BP) monitoring has emerged as a promising solution to overcome barriers to hypertension care access, yet validation of devices is lacking.
Methods
We conducted the validation of the Ideal Life BP Manager BP device, a remote BP monitoring device, using the AAMI/ESH/ISO protocol. From June 2021 to May 2022, participants were screened and systolic BP (SBP) and diastolic BP (DBP) measurements were conducted by trained staff using the Ideal Life BP Manager and a mercury sphygmomanometer. Statistical analyses were performed to assess agreement of SBP and DBP.
Results
Of the 90 individuals screened, 79 were included, with a mean age of 50.9 years (standard deviation [SD] 15.6) and the majority being female (68.8%). The mean ± SD differences between the Ideal Life BP Manager and mercury sphygmomanometer measurements were 2.20 ± 7.37 mm Hg for SBP and 1.49 ± 7.31 mm Hg for DBP, satisfying AAMI/ESH/ISO protocol criterion 1. Criterion 2 was also met, with participant-level standard deviations of the mean paired differences (6.54 mm Hg for SBP, 6.30 mm Hg for DBP) falling below the protocol-specified thresholds. Bland-Altman plots demonstrated limits of agreement of –12.0 to 16.9 mm Hg for systolic blood pressure and –12.8 to 15.9 mm Hg for diastolic blood pressure.
Conclusions
The Ideal Life BP Manager met the AAMI/ESH/ISO validation criteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL, United States.
- Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States.
- Department of Epidemiology, University of Alabama at Birmingham, University of Alabama at Birmingham, AL, United States.
- Department of Nephrology, University of Alabama at Birmingham, Birmingham, AL, United States.
- Department of Medicine, Vascular Biology and Hypertension Program, University of Alabama, Birmingham, AL, United States.
ORCID-Profile: Matthew D Moore, Ayamo Oben, Suzanne Oparil, Rachel R Sinkey
Förderung
- NIH
- NHLBI NIH HHS
- Center for Women's Reproductive Health Pilot
- Hypertension Research Center
- Nephrology Research & Training Center
- Division of Nephrology
- NHLBI
- Center for Women’s Reproductive Health Pilot
Zitieren
APA
Moore, M. D., Oben, A., Muntner, P., Harris, S., Saxon, N., Wallace, E., Oparil, S., Tita, A., & Sinkey, R. R. (2026). Validation of a remote monitoring blood pressure device in a general population cohort. American Journal of Hypertension, 39(9), 1076-1082. https://doi.org/10.1093/ajh/hpag042
Vancouver
Moore MD, Oben A, Muntner P, Harris S, Saxon N, Wallace E, et al. Validation of a remote monitoring blood pressure device in a general population cohort. American Journal of Hypertension. 2026;39(9):1076-1082. doi:10.1093/ajh/hpag042
BibTeX
@article{Moore2026,
author = {Moore, Matthew D and Oben, Ayamo and Muntner, Paul and Harris, Stacy and Saxon, Nancy and Wallace, Eric and Oparil, Suzanne and Tita, Alan and Sinkey, Rachel R},
title = {Validation of a remote monitoring blood pressure device in a general population cohort},
journal = {American Journal of Hypertension},
year = {2026},
volume = {39},
number = {9},
pages = {1076--1082},
doi = {10.1093/ajh/hpag042}
}
EUVIMED